The Patent Finder

Genitope Corporation

Also on record
Records under this name other than patents Genitope Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Genitope Corporation

PatentTitleStatus Expires Confidence
US 7,419,660Vaccines for treatment of lymphoma and leukemia
Term ended
Term ended May 1, 2016 · From the USPTO record
Term endedTerm ended May 1, 2016From the USPTO record
US 7,208,146Methods of treating lymphoma and leukemia
Lapsed on the fee record
Ended Apr 24, 2015 · From the USPTO record
Lapsed on the fee recordEnded Apr 24, 2015From the USPTO record
US 7,405,060Gene amplification methods
Lapsed on the fee record
Ended Jul 29, 2012 · From the USPTO record
Lapsed on the fee recordEnded Jul 29, 2012From the USPTO record
US 5,776,746Gene amplification methods
Term ended
Term ended no later than Jul 7, 2018 · Low confidence
Term endedTerm ended no later than Jul 7, 2018Low confidence
US 5,972,334Vaccines for treatment of lymphoma and leukemia
Term ended
Term ended no later than Oct 26, 2019 · Low confidence
Term endedTerm ended no later than Oct 26, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited